Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina
NCT00194324 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2011-08-09
Summary
This study uses MRI to detect the spread of the Miconozole Nitrate OVULE within the vagina. The effect of moderate amounts of physical activity on the spread will be evaluated, and compared to no physical activity.
Conditions
- Health
- Vulvovaginal Candidiasis
Interventions
- DRUG
-
Miconazole nitrate
- PROCEDURE
-
Magnetic resonance imaging
- BEHAVIORAL
-
Moderate levels of exercise
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Kurt T Barnhart, MD, MSCE · University of Pennsylvania
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-07-31
- Completion
- 2004-10-31
Countries
- United States
Study Locations
More Related Trials
-
Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment
NCT00934934 ·Status: TERMINATED ·Phase: PHASE2
-
Reducing Vaginal Infections in Women
NCT00170430 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Inflammation on Voriconazole Concentration
NCT02074462 ·Status: COMPLETED
-
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
NCT00105144 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
NCT05235711 ·Status: COMPLETED
-
Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
NCT03253094 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.
NCT00037219 ·Status: COMPLETED ·Phase: PHASE2
-
Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects
NCT04871724 ·Status: COMPLETED ·Phase: PHASE1
-
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
NCT02888197 ·Status: COMPLETED
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
NCT02734862 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia
NCT06907992 ·Status: NOT_YET_RECRUITING
-
Pharmacokinetics of Isavuconazole in Patients in the Intensive Care Unit
NCT04777058 ·Status: COMPLETED
-
An Observational Study of Fungal Biomarkers (MK-0000-089)
NCT00854607 ·Status: COMPLETED
-
A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235
NCT04464577 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects
NCT00940017 ·Status: COMPLETED ·Phase: PHASE4
-
Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
NCT00002040 ·Status: COMPLETED ·Phase: NA
-
ProF-001_Phase IIa
NCT03115073 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk Patients
NCT03652194 ·Status: UNKNOWN
-
Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis
NCT02242695 ·Status: COMPLETED ·Phase: PHASE4
-
Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections
NCT06387667 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy
NCT00136968 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis
NCT02244606 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.
NCT05031481 ·Status: WITHDRAWN ·Phase: PHASE2
-
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
NCT02475746 ·Status: WITHDRAWN ·Phase: PHASE1
-
Voriconazole to Treat Fungal Infections
NCT00001940 ·Status: COMPLETED ·Phase: PHASE3